Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Introduction to the round table discussion on intermediate uveitis].

E Bloch-Michel

    Bulletin De La Societe Belge D'Ophtalmologie
    |January 1, 1989
    PubMed
    Summary

    Intermediary uveitis, an eye inflammation, often persists long-term, with leakage across the entire hemato-ocular barrier contributing to prolonged disease. This suggests anatomical changes, not just immune responses, may drive persistent inflammation.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tear IgE detected by a new method: Stallerdiag-IgE.

    Ocular immunology and inflammation·2012
    Same author

    [Rhinoconjunctivitis: importance of a local diagnosis?].

    European annals of allergy and clinical immunology·2004
    Same author

    Comparison of lodoxamide 0.1% ophthalmic solution and levocabastine 0.05% ophthalmic suspension in vernal keratoconjunctivitis.

    European journal of ophthalmology·2001
    Same author

    Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.

    The British journal of ophthalmology·1999
    Same author

    Multiple sclerosis associated with uveitis in two large clinic-based series.

    Neurology·1999
    Same author

    Comparison of topical 0.05% levocabastine and 0.1% lodoxamide in patients with allergic conjunctivitis. Study Group.

    European journal of ophthalmology·1999

    Area of Science:

    • Ophthalmology
    • Immunology
    • Pathophysiology

    Context:

    • Intermediary uveitis presents diagnostic and therapeutic challenges.
    • Long-term follow-up data reveal persistent disease activity.

    Purpose:

    • To investigate the physiopathology of intermediary uveitis.
    • To explore factors contributing to the prolonged evolution of the disease.

    Summary:

    • Angiofluorophotometry reveals widespread hemato-ocular barrier leakage, not confined to anterior or posterior segments.
    • Barrier permeability often persists even after clinical resolution.
    • Prolonged disease may result from irreversible anatomical sequelae rather than solely immune processes.

    Impact:

    • Provides new insights into the pathophysiology of intermediary uveitis.
    • Suggests a shift in understanding the disease's chronicity.
    • May inform future treatment strategies focusing on barrier integrity.

    Related Experiment Videos